What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Corona Remedies Limited IPO?

Based on the upper price band of ₹1062 and current GMP of ₹344, the estimated listing price is ₹1406 (approx. 32.4% gain).

What is the expected profit per lot for Corona Remedies Limited IPO?

With a lot size of 14 shares and current GMP of ₹344, expected profit per retail application lot is approximately ₹4,816.

IPO GreyPremiumLIVE

Grey Market Intelligence

Corona Remedies Limited

ListedMainboard

Healthcare & Pharmaceuticals · NSE / BSE

Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.

Price Band

₹1008 – ₹1062

Issue Size

₹655 Cr

Lot Size

14 shares

GMP

₹344

+32.4%

Est. Listing

₹1406

at current GMP

Subscribed

144.49x

overall

Open

8 Dec 2025

10 Dec 2025

Allotment

11 Dec 2025

Refund

12 Dec 2025

Demat Credit

13 Dec 2025

Listing

15 Dec 2025

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Corona Remedies Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹344+32.4%

Issue Price (Upper)

₹1062

Band: ₹1008 – ₹1062

Estimated Listing Price

₹1406

Upper price + GMP

Lot Size

14 shares

Min investment ₹14,868

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹344	32.4%	₹1406
30 Oct 2026	+₹344	32.4%	₹1406
29 Oct 2026	+₹310	29.1%	₹1372

About Corona Remedies Limited Public Issue & Market Profile

Corona Remedies Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹655.37 Crores. The shares are offered at a price band of ₹1008 to ₹1062 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 14 shares (approx. ₹14,868 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-13, while un-allotted funds or UPI block mandates will be released on 2025-12-12.

Frequently Asked Questions

What is Corona Remedies Limited IPO GMP today?

The latest grey market premium for Corona Remedies Limited IPO is ₹344, which indicates an expected listing price of ₹1406.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.